BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

140 related articles for article (PubMed ID: 35977593)

  • 1. Papillary renal neoplasm with reverse polarity-a comparative study with CCPRCC, OPRCC, and PRCC1.
    Wang T; Ding X; Huang X; Ye J; Li H; Cao S; Gao Y; Ma X; Huang Q; Wang B
    Hum Pathol; 2022 Nov; 129():60-70. PubMed ID: 35977593
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Recurrent KRAS mutations identified in papillary renal neoplasm with reverse polarity-a comparative study with papillary renal cell carcinoma.
    Kim SS; Cho YM; Kim GH; Kee KH; Kim HS; Kim KM; Kim JH; Choi C
    Mod Pathol; 2020 Apr; 33(4):690-699. PubMed ID: 31953522
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Morphological, immunohistochemical, and genomic analyses of papillary renal neoplasm with reverse polarity.
    Kiyozawa D; Kohashi K; Takamatsu D; Yamamoto T; Eto M; Iwasaki T; Motoshita J; Shimokama T; Kinjo M; Oshiro Y; Yonemasu H; Oda Y
    Hum Pathol; 2021 Jun; 112():48-58. PubMed ID: 33811832
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Clinicopathological and molecular characterisation of papillary renal neoplasm with reverse polarity and its renal papillary adenoma analogue.
    Chang HY; Hang JF; Wu CY; Lin TP; Chung HJ; Chang YH; Pan CC
    Histopathology; 2021 Jun; 78(7):1019-1031. PubMed ID: 33351968
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Papillary renal neoplasm with reverse polarity with a favorable prognosis should be separated from papillary renal cell carcinoma.
    Liu Y; Zhang H; Li X; Wang S; Zhang Y; Zhang X; Xu T; Dong Y; Dong L; Zhou L; Yang X; Wang C
    Hum Pathol; 2022 Sep; 127():78-85. PubMed ID: 35724772
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Papillary renal neoplasm with reverse polarity: a clinicopathologic study of 43 cases with a focus on the expression of KRAS signaling pathway downstream effectors.
    Kim B; Lee S; Moon KC
    Hum Pathol; 2023 Dec; 142():1-6. PubMed ID: 37797754
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Frequent KRAS mutations in oncocytic papillary renal neoplasm with inverted nuclei.
    Tong K; Zhu W; Fu H; Cao F; Wang S; Zhou W; Liu C; Chen D; Fan S; Hu Z
    Histopathology; 2020 Jun; 76(7):1070-1083. PubMed ID: 31997427
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Papillary renal neoplasm with reverse polarity: a clinicopathological analysis].
    Ji RH; Wang XT; Li R; Ye SB; Wang X; Ma HH; Lu ZF; Rao Q; Xia QY
    Zhonghua Bing Li Xue Za Zhi; 2022 Jan; 51(1):23-27. PubMed ID: 34979749
    [No Abstract]   [Full Text] [Related]  

  • 9. Papillary Renal Neoplasm With Reverse Polarity: A Clinical, Pathologic, and Molecular Study of 8 Renal Tumors From a Single Institution.
    Nova-Camacho LM; Martin-Arruti M; Díaz IR; Panizo-Santos Á
    Arch Pathol Lab Med; 2023 Jun; 147(6):692-700. PubMed ID: 36170616
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Recurrent KRAS mutations are early events in the development of papillary renal neoplasm with reverse polarity.
    Al-Obaidy KI; Saleeb RM; Trpkov K; Williamson SR; Sangoi AR; Nassiri M; Hes O; Montironi R; Cimadamore A; Acosta AM; Alruwaii ZI; Alkashash A; Hassan O; Gupta N; Osunkoya AO; Sen JD; Baldrige LA; Sakr WA; Idrees MT; Eble JN; Grignon DJ; Cheng L
    Mod Pathol; 2022 Sep; 35(9):1279-1286. PubMed ID: 35152262
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Papillary renal cell carcinoma with cytologic and molecular genetic features overlapping with renal oncocytoma: Analysis of 10 cases.
    Michalova K; Steiner P; Alaghehbandan R; Trpkov K; Martinek P; Grossmann P; Montiel DP; Sperga M; Straka L; Prochazkova K; Cempirkova D; Horava V; Bulimbasic S; Pivovarcikova K; Daum O; Ondic O; Rotterova P; Michal M; Hora M; Hes O
    Ann Diagn Pathol; 2018 Aug; 35():1-6. PubMed ID: 30072012
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Oncocytic papillary renal cell carcinoma: a clinicopathological analysis of nineteen cases].
    Zhang W; Zhang LX; Yang T; Zou YW; Liu XL; Yu WJ; Jiang YX; Li YJ
    Zhonghua Bing Li Xue Za Zhi; 2022 Oct; 51(10):981-986. PubMed ID: 36207910
    [No Abstract]   [Full Text] [Related]  

  • 13. Non-coding RNA and gene expression analyses of papillary renal neoplasm with reverse polarity (PRNRP) reveal distinct pathological mechanisms from other renal neoplasms.
    Nemours S; Armesto M; Arestín M; Manini C; Giustetto D; Sperga M; Pivovarcikova K; Pérez-Montiel D; Hes O; Michal M; López JI; Lawrie CH
    Pathology; 2024 Jun; 56(4):493-503. PubMed ID: 38413252
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Papillary renal neoplasm with reverse polarity: an observational study of histology, immunophenotypes, and molecular variation.
    Han H; Yin SY; Song RX; Zhao J; Yu YW; He MX; Wang H
    Transl Androl Urol; 2024 Mar; 13(3):383-396. PubMed ID: 38590969
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Papillary renal neoplasm with reverse polarity: A clinicopathological and molecular genetic characterization of 16 cases with expanding the morphologic spectrum and further support for a novel entity.
    Shen M; Yin X; Bai Y; Zhang H; Ru G; He X; Teng X; Chen G; Zhao M
    Front Oncol; 2022; 12():930296. PubMed ID: 35936734
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Unilateral synchronous papillary renal neoplasm with reverse polarity and clear cell renal cell carcinoma: a case report with KRAS and PIK3CA mutations.
    Lee HJ; Shin DH; Park JY; Kim SY; Hwang CS; Lee JH; Kim JY; Sol MY; Nam JK
    Diagn Pathol; 2020 Oct; 15(1):123. PubMed ID: 33023600
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Papillary renal neoplasm with reverse polarity may be a novel renal cell tumor entity with low malignant potential.
    Yang T; Kang E; Zhang L; Zhuang J; Li Y; Jiang Y; Wang H; Yu W; Zhang W
    Diagn Pathol; 2022 Aug; 17(1):66. PubMed ID: 36002896
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Oncocytic papillary renal cell carcinoma: A clinicopathological and genetic analysis and indolent clinical course in 14 cases.
    Han G; Yu W; Chu J; Liu Y; Jiang Y; Li Y; Zhang W
    Pathol Res Pract; 2017 Jan; 213(1):1-6. PubMed ID: 27931799
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Papillary renal neoplasm with reverse polarity is biologically and clinically distinct from eosinophilic papillary renal cell carcinoma.
    Castillo VF; Trpkov K; Van der Kwast T; Rotondo F; Hamdani M; Saleeb R
    Pathol Int; 2024 Apr; 74(4):222-226. PubMed ID: 38456605
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Renal Neoplasms With Overlapping Features of Clear Cell Renal Cell Carcinoma and Clear Cell Papillary Renal Cell Carcinoma: A Clinicopathologic Study of 37 Cases From a Single Institution.
    Dhakal HP; McKenney JK; Khor LY; Reynolds JP; Magi-Galluzzi C; Przybycin CG
    Am J Surg Pathol; 2016 Feb; 40(2):141-54. PubMed ID: 26752401
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.